Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-γ in astrocytes

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4918-4926

  Caruso, Carla ^a   Durand, Daniela ^a   Schiöth, Helgi B ^c   Rey, Rodolfo ^a,b   Seilicovich, Adriana ^a   Lasaga, Mercedes ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BACTERIUM LIPOPOLYSACCHARIDE; CASPASE 3; CYCLOOXYGENASE 2; GAMMA INTERFERON; HORMONE RECEPTOR BLOCKING AGENT; HS 024; INDUCIBLE NITRIC OXIDE SYNTHASE; MELANOCORTIN 4 RECEPTOR; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALPHA-MSH; ANIMALS; APOPTOSIS; ASTROCYTES; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; CYCLOOXYGENASE 2 INHIBITORS; INFLAMMATION; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES, CYCLIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 34748907751     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0366     Document Type: Article

References (54)

1. Zhao G, Flavin M 2000 Differential sensitivity of rat hippocampal and cortical astrocytes to oxygen-glucose deprivation injury. Neurosci Lett 285:177-180
2. Smith SJ 1992 Do astrocytes process neural information? Prog Brain Res 94:119-136
3. Desagher S, Glowinski J, Premont J 1996 Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16:2553-2562
4. Dugan L, Bruno V, Amagasu S, Giffard R 1995 Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci 15:4545-4555
5. Garcia-Segura L, McCarthy M 2004 Role of glia in neuroendocrine function. Endocrinology 145:1082-1086
6. Mahesh V, Dhandapani K, Brann D 2006 Role of astrocytes in reproduction and neuroprotection. Mol Cell Endocrinol 246:1-9
7. Dong Y, Benveniste EN 2001 Immune function of astrocytes. Glia 36:180-190
8. Muñoz-Fernandez MA, Fresno M 1998 The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56:307-340
9. Ehrlich L, Peterson P, Hu S 1999 Interleukin (IL)-1β-mediated apoptosis of human astrocytes. Neuroreport 10:1849-1852
10. Pahan K, Khan M, Singh I 2000 Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase. J Neurochem 75:576-582
11. Saas P, Boucraut J, Quiquerez A, Schnuriger V, Perrin G, Desplat-Jego S, Bernard D, Walker P, Dietrich P 1999 CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J Immunol 162:2326-2333
12. Suk K, Lee J, Hur J, Kim YS, Lee M, Cha S, Yeou Kim S, Kim H 2001 Activation-induced cell death of rat astrocytes. Brain Res 900:342-347
13. Kim M, Cheong Y, So H, Lee K, Kim T, Oh J, Chung Y, Son Y, Kim B, Park R 2001 Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol 61:779-786
14. Takuma K, Baba A, Matsuda T 2004 Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72:111-127
15. Catania A, Gatti S, Colombo G, Lipton JM 2004 Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56:1-29
16. Sinha P, Schiöth H, Tatro J 2004 Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered α-MSH. Brain Res 1001:150-158
17. Starowicz K, Przewlocka B 2003 The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci 73:823-847
18. Liu G, Liu L, Lin C, Tseng J, Chuang M, Lam H, Lee J, Yang L, Chan J, Howng S, Tai M 2006 Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of α-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor κB/cyclooxygenase-2 pathway. Mol Pharmacol 69:440-451
19. Jo S, Yun S, Chang K, Cha D, Cho W, Kim H, Won N 2001 α-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Trans 16:1583-1591
20. Bohm M, Wolff I, Scholzen T, Robinson S, Healy E, Luger T, Schwarz T, Schwarz A 2005 α-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280:5795-5802
21. Lee S, Jo S, Cho W, Kim H, Won N 2004 The effect of α-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Transplantation 78:1756-1764
22. Hill R, Wheeler P, Macneil S, Haycock J 2005 α-Melanocyte stimulating hormone cytoprotective biology in human dermal fibroblast cells. Peptides 26:1150-1158
23. Sarkar A, Sreenivasan Y, Manna S 2003 α-Melanocyte- stimulating hormone induces cell death in mast cells: involvement of NF-κB. FEBS Lett 549:87-93
24. Tatro J 1996 Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation 3:259-284
25. Chaki S, Okuyama S 2005 Involvement of melanocortin-4 receptor in anxiety and depression. Peptides 26:1952-1964
26. Giuliani D, Mioni C, Altavilla D, Leone S, Bazzani C, Minutoli L, Bitto A, Cainazzo M, Marini H, Zaffe D, Botticelli A, Pizzala R, Savio M, Necchi D, Schioth HB, Bertolini A, Squadrito F, Guarini S 2006 Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147:1126-1135
27. Ramirez G, Toro R, Dobeli H, von Bernhardi R 2005 Protection of rat primary hippocampal cultures from Aβ cytotoxicity by pro-inflammatory molecules is mediated by astrocytes. Neurobiol Dis 19:243-254
28. Bal-Price A, Brown G 2001 Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480-6491
29. Hemmer K, Fransen L, Vanderstichele H, Vanmechelen E, Heuschling P 2001 An in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric oxide and tumor necrosis factor-α. Neurochem Int 38:557-565
30. Caruso C, Mohn C, Karara A, Rettori V, Watanobe H, Schioth H, Seilicovich A, Lasaga M 2004 α-Melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 79:278-286
31. Kask A, Mutulis F, Muceniece R, Pahkla R, Mutule I, Wikberg JE, Rago L, Schioth HB 1998 Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology 139:5006-5014
32. McCarthy K, de Vellis J 1980 Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902
33. Caruso C, Bottino MC, Pampillo M, Pisera D, Jaita G, Duvilanski B, Seilicovich A, Lasaga M 2004 Glutamate induces apoptosis in anterior pituitary cells through group II metabotropic glutamate receptor activation. Endocrinology 145:4677-4684
34. Gatti S, Colombo G, Turcatti F, Lonati C, Sordi A, Bonino F, Lipton JM, Catania A 2006 Reduced expression of the melanocortin-1 receptor in human liver during brain death. Neuroimmonomodulation 13:51-55
35. Mountjoy K, Guan J, Elia C, Sirimanne E, Williams C 1999 Melanocortin-4 receptor messenger RNA expression is up-regulated in the non-damaged striatum following unilateral hypoxic-ischaemic brain injury. Neuroscience 89:183-190
36. Tatro J 2006 Melanocortins defend their territory: multifaceted neuroprotection in cerebral ischemia. Endocrinology 147:1122-1125
37. Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM, Friedman JM, Elmquist JK 2003 Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23:7143-7154
38. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JK 2003 Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 457:213-235
39. Selkirk JV, Nottebaum LM, Lee J, Yang W, Foster AC, Lechner SM 2007 Identification of differential melanocotin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology 52:459-466
40. Lam C, Getting S 2004 Melanocortin receptor type 3 as a potential target for anti-inflammatory therapy. Curr Drug Targets Inflamm Allergy 3:311-315
41. Ichiyama T, Zhao H, Catania A, Furukawa S, Lipton JM 1999 α-Melanocytestimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 157:359-365
42. Minghetti L 2004 Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63:901-910
43. Pistritto G, Franzese O, Pozzoli G, Mancuso C, Tringali G, Preziosi P, Navarra P 1999 Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor κB. Biochem Biophys Res Commun 263:570-574
44. Yoon SW, Goh SH, Chun JS, Cho EW, Lee MK, Kim KL, Kim JJ, Kim CJ, Poo H 2003 α-Melanocyte-stimulating hormone inhibits lipopolysaccharide- induced tumor necrosis factor-α production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor κB signaling pathways. J Biol Chem 278:32914-32920
45. Wikberg JES 1999 Melanocortin receptors: perspectives for novel drugs. Eur J Pharmacol 375:295-310
46. Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, Lipton JM 1999 Systemically administered α-melanocyte-stimulating peptides inhibit NF-κB activation in experimental brain inflammation. Brain Res 836:31-37
47. Viviani B, Bartesaghi S, Corsini E, Galli C, Marinovich M 2004 Cytokines role in neurodegenerative events. Toxicol Lett 149:85-89
48. Papadopoulos MC, Koumenis I, Xu L, Giffard R 1998 Potentiation of murine astrocyte antioxidant defense by bcl-2: protection in part reflects elevated glutathione levels. Eur J Neurosci 10:1252-1260
49. Ouyang Y, Giffard R 2004 Changes in astrocyte mitochondrial function with stress: effects of Bcl-2 family proteins. Neurochem Int 45:371-379
50. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka M 2005 Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 30:144-157
51. Wu X, Deng Y 2002 Bax and BH3-domain-only proteins in p53-mediated apoptosis. Front Biosci 17:151-156
52. Montminy M 1997 Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66:807-822
53. Persengiev S, Green M 2003 The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 8:225-228
54. Dawson T, Ginty D 2002 CREB family transcription factors inhibit neuronal suicide. Nat Med 8:450-451